Pharmacokinetic properties of recombinant porcine growth hormone in pigs

O. Y.P. Hu, W. C. Chang, T. S. Yang

Research output: Contribution to journalArticle

Abstract

The plasma pharmacokinetic profile of recombinant porcine growth hormone (rpGH) was studied in six healthy gilts after a rapid single i.v. injection of 250 μg/kg rpGH. The linear pharmacokinetic properties of rpGH were investigated by giving four different doses of the hormone at intervals of 2 days. The plasma rpGH concentration was determined by radioimmunoassay with a lowest detection limit of 50 pg/ml. Plasma levels of rpGH were fitted to a three-compartment open model; a triexponential decrease in plasma rpGH with a rather long mean terminal half-life of 40.22 ± 5.623 min was obtained in these pigs. Linear pharmacokinetic properties of rpGH were confirmed in the additional pig that received doses between 25 and 250 μg/kg rpGH. The small volume of distribution, 0.029 ± 0.003 l/kg, indicated that most of the injected rpGH was confined to the blood and probably lymph. The total plasma clearance of rpGH was 31.80 ± 2.802 ml/h x kg. The results not only contribute significantly to our knowledge about rpGH pharmacokinetics, but also to future studies for the rational design of optimal dosage regimens and the development of a controlled-release device for rpGH.

Original languageEnglish
Pages (from-to)63-68
Number of pages6
JournalPharmacology
Volume50
Issue number1
Publication statusPublished - Jan 1 1995
Externally publishedYes

Fingerprint

Growth Hormone
Swine
Pharmacokinetics
Lymph
Radioimmunoassay
Half-Life
Limit of Detection
Hormones

Keywords

  • Half-life
  • Linear pharmacokinetic property
  • Pharmacokinetics
  • Radioimmunoassay
  • Recombinant porcine growth hormone

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hu, O. Y. P., Chang, W. C., & Yang, T. S. (1995). Pharmacokinetic properties of recombinant porcine growth hormone in pigs. Pharmacology, 50(1), 63-68.

Pharmacokinetic properties of recombinant porcine growth hormone in pigs. / Hu, O. Y.P.; Chang, W. C.; Yang, T. S.

In: Pharmacology, Vol. 50, No. 1, 01.01.1995, p. 63-68.

Research output: Contribution to journalArticle

Hu, OYP, Chang, WC & Yang, TS 1995, 'Pharmacokinetic properties of recombinant porcine growth hormone in pigs', Pharmacology, vol. 50, no. 1, pp. 63-68.
Hu, O. Y.P. ; Chang, W. C. ; Yang, T. S. / Pharmacokinetic properties of recombinant porcine growth hormone in pigs. In: Pharmacology. 1995 ; Vol. 50, No. 1. pp. 63-68.
@article{3eca5d92ecfb42908f0b7486a8f1c917,
title = "Pharmacokinetic properties of recombinant porcine growth hormone in pigs",
abstract = "The plasma pharmacokinetic profile of recombinant porcine growth hormone (rpGH) was studied in six healthy gilts after a rapid single i.v. injection of 250 μg/kg rpGH. The linear pharmacokinetic properties of rpGH were investigated by giving four different doses of the hormone at intervals of 2 days. The plasma rpGH concentration was determined by radioimmunoassay with a lowest detection limit of 50 pg/ml. Plasma levels of rpGH were fitted to a three-compartment open model; a triexponential decrease in plasma rpGH with a rather long mean terminal half-life of 40.22 ± 5.623 min was obtained in these pigs. Linear pharmacokinetic properties of rpGH were confirmed in the additional pig that received doses between 25 and 250 μg/kg rpGH. The small volume of distribution, 0.029 ± 0.003 l/kg, indicated that most of the injected rpGH was confined to the blood and probably lymph. The total plasma clearance of rpGH was 31.80 ± 2.802 ml/h x kg. The results not only contribute significantly to our knowledge about rpGH pharmacokinetics, but also to future studies for the rational design of optimal dosage regimens and the development of a controlled-release device for rpGH.",
keywords = "Half-life, Linear pharmacokinetic property, Pharmacokinetics, Radioimmunoassay, Recombinant porcine growth hormone",
author = "Hu, {O. Y.P.} and Chang, {W. C.} and Yang, {T. S.}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "50",
pages = "63--68",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Pharmacokinetic properties of recombinant porcine growth hormone in pigs

AU - Hu, O. Y.P.

AU - Chang, W. C.

AU - Yang, T. S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The plasma pharmacokinetic profile of recombinant porcine growth hormone (rpGH) was studied in six healthy gilts after a rapid single i.v. injection of 250 μg/kg rpGH. The linear pharmacokinetic properties of rpGH were investigated by giving four different doses of the hormone at intervals of 2 days. The plasma rpGH concentration was determined by radioimmunoassay with a lowest detection limit of 50 pg/ml. Plasma levels of rpGH were fitted to a three-compartment open model; a triexponential decrease in plasma rpGH with a rather long mean terminal half-life of 40.22 ± 5.623 min was obtained in these pigs. Linear pharmacokinetic properties of rpGH were confirmed in the additional pig that received doses between 25 and 250 μg/kg rpGH. The small volume of distribution, 0.029 ± 0.003 l/kg, indicated that most of the injected rpGH was confined to the blood and probably lymph. The total plasma clearance of rpGH was 31.80 ± 2.802 ml/h x kg. The results not only contribute significantly to our knowledge about rpGH pharmacokinetics, but also to future studies for the rational design of optimal dosage regimens and the development of a controlled-release device for rpGH.

AB - The plasma pharmacokinetic profile of recombinant porcine growth hormone (rpGH) was studied in six healthy gilts after a rapid single i.v. injection of 250 μg/kg rpGH. The linear pharmacokinetic properties of rpGH were investigated by giving four different doses of the hormone at intervals of 2 days. The plasma rpGH concentration was determined by radioimmunoassay with a lowest detection limit of 50 pg/ml. Plasma levels of rpGH were fitted to a three-compartment open model; a triexponential decrease in plasma rpGH with a rather long mean terminal half-life of 40.22 ± 5.623 min was obtained in these pigs. Linear pharmacokinetic properties of rpGH were confirmed in the additional pig that received doses between 25 and 250 μg/kg rpGH. The small volume of distribution, 0.029 ± 0.003 l/kg, indicated that most of the injected rpGH was confined to the blood and probably lymph. The total plasma clearance of rpGH was 31.80 ± 2.802 ml/h x kg. The results not only contribute significantly to our knowledge about rpGH pharmacokinetics, but also to future studies for the rational design of optimal dosage regimens and the development of a controlled-release device for rpGH.

KW - Half-life

KW - Linear pharmacokinetic property

KW - Pharmacokinetics

KW - Radioimmunoassay

KW - Recombinant porcine growth hormone

UR - http://www.scopus.com/inward/record.url?scp=0028817696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028817696&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 63

EP - 68

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 1

ER -